好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Pilot Study: Use of Rapid Response EEG Headset on C-130
Epilepsy/Clinical Neurophysiology (EEG)
P11 - Poster Session 11 (5:30 PM-6:30 PM)
1-010
 Evaluate the (1) ability of medic students and CCAT team to utilize, interpret, and make clinical decisions based on rr-EEG devices and (2) determine usability of the device on a CCAT.
Non-convulsive status epilepticus (NCSE) and non-convulsive seizures (NCS) occur in up to 20% of patients with traumatic brain injuries (TBI). These seizures often have no observable bedside correlate. The standard of care is an electroencephalogram (EEG), which requires a specially trained technician to place complex and unwieldly electrodes over the scalp and interpretation by a neurologist. The machine itself is cumbersome, large and requires a reliable power source. As a result, it is not feasible to obtain EEGs in an austere environment or during patient transport with a critical care air transport (CCAT) team. Typically, EEG capabilities are not accessible until a patient is sent to a receiving hospital. An unanswered question is how to address NCSE in CC air transport situations despite these limitations.
We completed simulations implementing the rr-EEG headset that mimicked a combat situation downrange with medic students. A simulation utilizing the rr-EEG headset was also accomplished on a training mission with a CCAT team on an airborne C-130 that included a respiratory therapist, ICU nurse, and Pulmonary/Critical Care fellow. Both simulations were aimed at determining if these populations could determine NCS in out-of-hospital environments.

26 of 28 medic students were able to distinguish NCS vs normal on the rr-EEG headset utilizing the sound stethoscope. The CCAT team was able to positively differentiate NCS from normal activity on the rr-EEG headset and make clinical decisions while in flight, something that has never been done before.

This pilot study demonstrates that this technology can be utilized in austere environments and during medical transport to reduce delays in diagnosing NCS, potentially improving morbidity and mortality for injured servicemembers.
Authors/Disclosures
Joshua Luster, MD
PRESENTER 		Dr. Luster has nothing to disclose.
William Hoffman, MD (United States Air Force) The institution of Dr. Hoffman has received research support from United States Air Force. Dr. Hoffman has a non-compensated relationship as a Member with United States Air Force that is relevant to AAN interests or activities.
Morgan Jordan, DO Dr. Jordan has nothing to disclose.
Zahari Tchopev, MD (Brooke Army Medical Center Department of Neurology) Dr. Tchopev has nothing to disclose.
Kelsey Cacic, MD The institution of Dr. Cacic has received research support from Texas Neurological Society.
Adam M. Willis, MD The institution of Dr. Willis has received research support from Air Force. Dr. Willis has received intellectual property interests from a discovery or technology relating to health care.